Powered by: Motilal Oswal
2026-03-27 10:19:22 am | Source: Accord Fintech
Infosys moves up on inking pact to acquire Optimum Healthcare IT
Infosys moves up on inking pact to acquire Optimum Healthcare IT

Infosys is currently trading at Rs. 1288.10, up by 8.75 points or 0.68% from its previous closing of Rs. 1279.35 on the BSE.

The scrip opened at Rs. 1278.00 and has touched a high and low of Rs. 1295.00 and Rs. 1277.95 respectively. So far 128799 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1727.85 on 03-Feb-2026 and a 52 week low of Rs. 1215.15 on 17-Mar-2026.

Last one week high and low of the scrip stood at Rs. 1296.70 and Rs. 1227.55 respectively. The current market cap of the company is Rs. 524753.01 crore.

The promoters holding in the company stood at 14.52%, while Institutions and Non-Institutions held 71.55% and 13.93% respectively.

Infosys has signed definitive agreement to acquire Optimum Healthcare IT, recognized as a Best in KLAS healthcare digital transformation and consulting firm recognized for helping provider organizations drive large-scale transformation.

The acquisition of Optimum Healthcare IT underscores Infosys’ commitment to strengthening its healthcare capabilities, particularly in collaboration with health systems and provider organizations to deliver measurable outcomes across complex clinical and operational environments. Optimum Healthcare IT brings deep provider-domain expertise and a proven delivery model - making it a strong strategic fit for Infosys’ scale and healthcare growth strategy. This investment significantly enhances Infosys’ presence in the provider segment, adding new clients and relationships, expanding technology capabilities, and creating synergies across new buying centers. Healthcare providers served by Optimum Healthcare IT will now have access to Infosys’ broader offerings across Infosys Topaz AI offerings, Infosys Cobalt cloud offerings, cloud engineering, infrastructure services, cybersecurity and application transformation.

The transaction is expected to close during the first quarter of FY 2027, subject to regulatory approvals and completion of closing conditions.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here